Stanford’s Shenandoah Therapeutics Secures $21.5M for Cancer Innovation
Shenandoah Therapeutics, a spinout from Stanford University, has successfully raised $21.5 million in funding to develop innovative cancer therapies that leverage the body’s own mechanisms. This funding round, announced in…